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Chronic wounds afford a hostile environment of damaged tissues that allow bacterial
proliferation and further wound colonization. Escherichia coli is among the most
common colonizers of infected wounds and it is a prolific biofilm former. Living in biofilm
communities, cells are protected, become more difficult to control and eradicate, and
less susceptible to antibiotic therapy. This work presents insights into the proceedings
triggering E. coli biofilm control with phage, honey, and their combination, achieved
through standard antimicrobial activity assays, zeta potential and flow cytometry studies
and further visual insights sought by scanning electron microscopy and transmission
electron microscopy. Two Portuguese honeys (PF2 and U3) with different floral origin
and an E. coli-specific phage (EC3a), possessing depolymerase activity, were tested
against 24- and 48-h-old biofilms. Synergic and additive effects were perceived in
some phage–honey experiments. Combined therapy prompted similar phenomena in
biofilm cells, visualized by electron microscopy, as the individual treatments. Honey
caused minor membrane perturbations to complete collapse and consequent discharge
of cytoplasmic content, and phage completely destroyed cells leaving only vesicle-
like structures and debris. Our experiments show that the addition of phage to low
honey concentrations is advantageous, and that even fourfold diluted honey combined
with phage, presents no loss of antibacterial activity toward E. coli. Portuguese honeys
possess excellent antibiofilm activity and may be potential alternative therapeutic agents
in biofilm-related wound infection. Furthermore, to our knowledge this is the first
study that assessed the impacts of phage–honey combinations in bacterial cells. The
synergistic effect obtained was shown to be promising, since the antiviral effect of honey
limits the emergence of phage resistant phenotypes.
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INTRODUCTION
Chronic wounds take months, years or may even never heal and present a major biological and
financial problem on both individual patients and the broader health system. All chronic wounds
show a diversified microflora in the deep dermal tissues where the main prevalent populations
evident include Staphylococcus, Escherichia coli, Pseudomonas, Enterobacter, Stenotrophomonas,
Streptococcus, and Serratia among other (Petkovšek et al., 2009; Price et al., 2009; Han et al.,
2011; Rhoads et al., 2012). Furthermore, the ability of these microorganisms to colonize
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and form biofilms is one of the main healing obstacles. Biofilms
are structured communities of bacterial cells enclosed in a
self-produced polymeric matrix and adhered to an inert or
living surface (Costerton et al., 1999). Biofilms are formed in
a sequential cycle of discrete and well-regulated events starting
from: (i) adsorption of macro and smaller molecules to surfaces;
(ii) bacterial adhesion to the wound surface and expression
of extracellular polymeric substances (EPS); (iii) microcolony
formation and biofilm maturation. Cell aggregation in these
biofilm communities are well known to block antibiotics from
reaching bacteria and also block host’s immune cells contrarily
to their planktonic counterparts which lack structure and
are not surrounded by a polymeric matrix (Costerton and
Lewandowski, 1995; Stewart and William Costerton, 2001; Fux
et al., 2005). Occasionally, clusters of biofilms detach from
the biofilm structure and start biofilm formation in new sites
(Costerton et al., 1999). In wounds, the biofilm matrix, consisting
of both EPS and host-derived matrix (e.g., fibrin and collagen),
undeniably has influence in the penetration of certain antibiotics.
This is mainly due to the overall negative net charge of the
matrix that can sequester for instance the positively charged
antibiotic tobramycin while readily allowing neutral antibiotics
to penetrate the biofilm (Tseng et al., 2013). Besides protection
to antimicrobials and host defenses, the biofilm mode of growth
confers protection to the microorganism from mechanical and
shear forces (McCarty et al., 2012) and also from altered pH,
osmolarity, and nutrient limitation (Costerton et al., 1999; Fux
et al., 2005).
Honey is a complex substance made up of hundreds of
different compounds. Honey’s antimicrobial activity was initially
attributed to the high sugar content and low pH and later
to the activity of glucose oxidase which catalyses glucose
to form hydrogen peroxide and gluconic acid (Henriques
et al., 2005; Mandal and Mandal, 2011; Maddocks and
Jenkins, 2013; McLoone et al., 2016). In 1988, it was found
that some honeys, mainly derived from the manuka shrub
(Leptospermum scoparium) still retained their antimicrobial
activity when catalase was added (inactivating hydrogen
peroxide) to the diluted honey (Allen et al., 1991). This
non-peroxide antimicrobial activity of Manuka honey has
been attributed to the presence of methylglyoxal (MGO), an
α-oxoaldehyde that reacts with important biological molecules
such as RNA, DNA and proteins (Kalapos, 1999; Blair et al., 2009;
Majtan et al., 2012). MGO is a product of the acidic breakdown
of dihydroxyacetone (DHA) which is set off by the addition
of glucose oxidase by bees while processing honey (Van Eaton,
2014). Honey has a broad spectrum antibacterial activity against
bacteria (Cooper et al., 1999) and its high viscosity provides
a protective barrier against infections being suitable for skin
care, promoting the wound healing, tissue regeneration and anti-
inflammatory process (Mandal and Mandal, 2011; Belcher, 2012).
Before the discovery of modern antibiotics, bacteriophages
(phages) that are bacterial viruses, and bee hive products
such as honey were extensively used for their antimicrobial
properties. In fact, the use of honey dates back at 4,000 years,
to Ancient Egypt where it was used for the treatment of wounds
among other conditions (Cooper, 2005). On the other hand,
phages were widely used in the 1920s and 1930s by physicians
whom successfully treated a variety of infections. Even after
the widespread of antibiotics, phage therapy continued in many
countries, such as Georgia, Poland, and Russia (Kutateladze and
Adamia, 2010).
Phages are harmless to mammalian cells and are specific for a
target bacteria, therefore do not affect the commensal microflora
(Hanlon, 2007; Azeredo and Sutherland, 2008; Kutateladze and
Adamia, 2010). In contrast with antibiotics, phages have the
ability to self-replicate as long as the host is present which implies
that a single dose is sufficient. There is, however, an overall lack
of studies comparing the effectiveness of phage products with
the standard wound care treatments. The few reports assessing
the effectiveness of phages and antibiotics on wounds show that
postoperative wound infections in cancer patients (Kochetkova
et al., 1989) and also postsurgical wounds (Sakandelidze and
Meipariani, 1974) had a higher healing success with phage. In a
recent study, a commercial preparation of staphylococcal phage
Sb-1 was used in patients with diabetic toe ulcers after poor
response to conventional therapy (Fish et al., 2016). Ulcers of
all patients treated with phage healed, and no adverse effect,
tissue breakdown or recurrence of infection were observed.
This reinforces one of the major attractive features that has
resulted in phage comeback as potential alternatives to commonly
used antimicrobials which is the fact that they are effective
against antibiotic resistant bacteria (Sillankorva and Azeredo,
2014). Another attractive characteristic is that, although phages
interaction with biofilm populations is not thoroughly studied,
many in vitro reports acknowledge that phages can destroy, to
varying extent, mono and mixed biofilm populations (Doolittle
et al., 1995; Pires et al., 2011; Melo et al., 2016).
Although modern antibiotics use has meant a decrease in
mortality, its widespread use has led to the emergence of
antibiotic-resistant bacteria decreasing the treatment options
(Cooper, 2005). Considering wound therapy in particular, there
are currently no guidelines for patients with infected wounds.
This frequently leads clinicians to prescribe antibiotic therapy
until healing occurs even if there is no evidence that supports this
practice. This misuse in patients with infected and many times
even uninfected wounds eventually lead to antibiotic-resistant
infections. The European Wound Management Association and
the British Society for Antimicrobial Chemotherapy have recently
assembled the principles of wound management, antibiotic
treatment, and stewardship to provide practical guidance (Lipsky
et al., 2016). In this publication, the authors strongly advise to
avoid using antibiotics topically for treating wound infections.
The efficiency denoted by the use of honey and phages alone
against antibiotic-resistant bacteria and biofilms has raised
significant interest for topic use in infected wounds. Manuka
honey dressings, gel and ointments are commercially available for
topical application in human and pet wounds, and studies have
shown that its antimicrobial properties accelerate chronic wound
healing (Jull et al., 2007; Gethin and Cowman, 2008; Robson
et al., 2009). Also, in vivo phage studies in rat and pig models
suggest that phages are an effective treatment of cutaneous
infected wounds (Mendes et al., 2013). A physician-initiated
FDA-approved phase I safety trial of phage therapy against skin
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ulcerations was completed already in 2008 and showed that
phages caused no side effects on the patients (Rhoads et al.,
2009). Furthermore, PhagoBioDerm (PolymerPharm, Georgia),
a biodegradable product with phages and other medications, is
marketed for human application.
The study described herein is the first combining honey
and phages. The chosen bacterial target was E. coli, one of the
most frequently isolated Gram-negative pathogens from chronic
wounds (Mangram et al., 1999). The effect of the combined
application of both antimicrobial agents was compared with
the efficacy of honey and phage alone. The phage used in this
work, EC3a, was isolated from raw sewage and infected 12 of 31
multidrug resistant E. coli clinical isolates (Andrade, 2014).
MATERIALS AND METHODS
Bacterial Strains and Growth Conditions
Escherichia coli reference strain CECT 434 was purchased from
the Spanish Type Culture Collection and the clinical isolate
EC3a was kindly provided by the Hospital Escala Braga in
Portugal. E. coli EC3a was used as phage propagation strain
and E. coli CECT 434 in all biofilm experiments. Both strains
were grown at 37◦C in tryptic soy broth (TSB, VWR) or in
solid tryptic soy agar (TSA) medium [TSB containing 1.5% (w/v)
of NZYTech agar] and for viable cell counts MacConkey Agar
(Merck R©) was used. E. coli K12 JM109, Pseudomonas aeruginosa
PAO1, Staphylococcus aureus ATCC 19685 and a clinical isolate
Acinetobacter pittii CEB-Ap (Oliveira et al., 2017) were included
in this study to determine the minimum inhibitory concentration
(MIC) of the different Portuguese honeys.
Bacteriophage Isolation and Production
Phage vB_EcoS_CEB_EC3a, mentioned below as EC3a, was
isolated from raw sewage using the clinical isolate EC3a as
host (Andrade, 2014). EC3a production was carried out in
its isolation host, using the plate lysis and elution method
(Sambrook and Russell, 2001). Briefly, 5 µL of phage suspension
were spread evenly on host bacterial lawns using a paper strip
and incubated overnight at 37◦C. Afterward, 3 mL of SM buffer
(5.8 g.L−1 NaCl, 2 g.L−1 MgSO4.7H2O, 50 mL.L−1 1 M Tris–
HCl pH 7.5, VWR) were added to each plate and incubated
overnight at 4◦C with gentle stirring (50 rpm on a PSU-10i
Orbital Shaker; BIOSAN). Subsequently, all liquid was collected,
centrifuged (10 min, 9,000 × g, 4◦C). The supernatant was
collected, phages further concentrated with PEG 8000 (Thermo
Fisher Scientific), purified with chloroform, filter sterilized (PES,
GE Healthcare, 0.2 µm) and stored at 4◦C until use. The
diameter of six individual phage plaques (plaque and halo) were
registered.
Honey Samples
A total of 13 Portuguese honeys from different geographic
origins, harvested during 2015–2016 were collected from regional
beekeepers. All honey samples were raw and unprocessed, and
were maintained in the dark at room temperature until analysis
and use in antimicrobial experiments. Commercial 100% medical
grade Manuka honey (Medihoney R©, Derma Sciences) was also
analyzed in this study.
Physicochemical Characterization of
Honey
The following physicochemical parameters were assessed:
pH, color, and protein content (Supplementary Table S1).
The pH and color were determined according to official
methods recommended by the International Honey Commission
and US National Honey Board (Bogdanov et al., 2002).
Honeys were categorized according to the reference table of
the United States Department of Agriculture (United States
Department of Agriculture, 1985). The protein content of honeys
was determined using the BCA Protein Assay Kit (Thermo
ScientificTM PierceTM) following manufacturer’s instructions.
Pollen analysis and conductivity were only determined for
honeys used in the antibiofilm experiments—U3 and PF2
(Supplementary Table S2), respectively.
Hydroxymethylfurfural Content of Honey
Hydroxymethylfurfural (HMF) content of honeys was
determined using the method described by White (1979).
Briefly, 0.5 g of each honey was weighed into a 50 mL flask
containing 12.5 mL of water and 0.25 mL of Carrez Solution I
(150 mg.mL−1 potassium ferrocyanide, Sigma). The solution
was homogenized, 0.25 mL of Carrez solution II (300 mg.mL−1
zinc acetate, Biochem Chemopharma) was added and the volume
adjusted with distilled water to achieve 25 mL. All solutions
were filtered (PES, 0.22 µm). A volume of 2.5 mL of each
honey sample was collected to two 15 mL tubes: (i) 2.5 mL
of water were added to tube 1, and (ii) 2.5 mL of 0.20% (w/v)
sodium bisulfite (Sigma) were added to tube 2. The solutions
were mixed and turbidimetry measured at 284 nm (A284) and
336 nm (A336) (UV-3100PC VWR Spectrometer). The HMF
content was calculated using the formula HMF (mg.kg−1 of
honey)= (A284 − A336)× 149.7× 5/[weight of sample (g)].
Methylglyoxal Content of Honey
MGO of honeys was detected and quantified by reverse phase-
high pressure liquid chromatography (RP-HPLC) of the corres-
ponding quinoxalines that resulted from derivatization with
o-phenylenediamine (OPD, Amresco) (Adams et al., 2008). The
RP-HPLC method was performed in a Shimadzu R© instrument,
using a C18 column (Merck R©). First, derivatization steps were
performed, in order to obtain MGO (and DHA an OPD-
derivative). For this, approximately 0.6 g of honey were dissolved
in ultra-pure water [30% (w/v)] and mixed with 750 µL of 2%
(w/v) OPD solution in 0.5 M phosphate buffer (pH 6.5). Samples
were then incubated at room temperature in the dark for 16 h and
membrane filtered (PES, 0.22 µm) before HPLC running.
The mobile phases used for HPLC were 0.075% (v/v) acetic
acid (Fisher Chemical) in water (solvent A) and 80% (v/v)
methanol (Biochem Chemopharma) in water (solvent B), in a 1:1
(v/v) proportion. The gradient started with 10% (v/v) solvent B
for 4 min and then was elevated gradually to 100% B over a period
of 31 min, and was held there for 3 min, and changed back to
10% (v/v) B in 6 min. The flow rate was 0.3 mL.min−1 and the
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separation was performed at 30◦C. A volume of 20 µL of sample
solution was injected and peaks were detected by measurement
of UV absorbance at 312 nm. Quantification was achieved by
external calibration with standard solution for MGO using a
grade solvent MGO of 35–40% (v/v) (Alfa Aesar). Finally, MGO
was eluted after about 21 min.
Determination of the Minimum Inhibitory
Concentration of Honey
MIC of honeys was determined using the broth microdilution
method described in the guidelines of the Clinical and Laboratory
Standards Institute [CLSI, Wayne, NJ, United States (M27-A2)]
(Andrews and Andrews, 2001; Ferraro et al., 2003). Briefly,
fresh colonies of E. coli, P. aeruginosa, S. aureus, and A. pittii
were selected from TSA plates, transferred to 10 mL of TSB
and incubated at 37◦C, 120 rpm for 16 h. The turbidity of the
bacterial culture at 620 nm was adjusted to 0.13 [approximately
3 × 108 colony forming unit (CFU).mL−1; Synergy
HT—BioTek] and diluted 30-fold in TSB. MICs were determined
in a 96-well flat bottom plates (Orange Scientific) using a final
volume of 100 µL. Honey concentrations ranged from 50%
(w/v) to 3.125% (w/v). Plates were incubated for 20 h at 37◦C
and growth inhibition confirmed visually and by turbidimetry
(620 nm, Synergy HT—BioTek). Five independent experiments
were performed in triplicate.
Phage DNA Extraction and Genome
Sequencing
DNA of phage EC3a was extracted as described before (Melo
et al., 2014). Purified phages were treated with 0.016% (v/v) L1
buffer [300 mM NaCl, 100 mM Tris–HCl (pH 7.5), 10 mM EDTA
(Amresco), 0.2 mg.mL−1 BSA, 20 mg.mL−1 RNase A (Sigma),
6 mg.mL−1 DNase I (Sigma)] for 2 h at 37◦C. The enzymes were
subjected to a thermal inactivation for 30 min at 65◦C. Then,
50 µg.mL−1 proteinase K (NZYTech), 20 mM EDTA, and 1%
(w/v) SDS (Sigma) were added to digest proteins for 18 h at
56◦C. This was followed by phenol:chloroform:isoamyl alcohol
solution (25:24:1, v/v; Thermo Fisher Scientific) and chloroform
(Thermo Fisher Scientific) extractions. DNA was precipitated
with isopropanol and 3 M sodium acetate (pH 4.6) (Thermo
Fisher Scientific), centrifuged (15 min, 7,600 × g, 4◦C), and the
pellet air-dried. The pellet was resuspended in nuclease-free water
(GE Healthcare).
Genome sequencing was performed on an Illumina HiSeq
platform (STAB VIDA). EC3a genome was mixed at equimolar
ratios with a non-homologous phage, and subjected to quality
controls using an Agilent Bioanalyzer. DNA library preparations
were prepared using KAPA DNA Library (KAPA Biosystems)
to generate 200-bp fragments with 2 × 100 bp paired-end
read length configuration. After processing, reads were trimmed
to remove adapters, contaminations, or low-quality sequences.
Contigs were assembled with a relatively homogenous coverage
with the CLC genomics Workbench version 7 (CLC Bio) using
the de novo assembly algorithm and manual inspection. EC3a
phage genome was autoannotated, using MyRAST (Aziz et al.,
2008) and the presence of non-annotated CDSs, along with
genes in which the initiation codon was miscalled, were checked
manually using Geneious 9.1.4 (Biomatters), and potential
frameshifts were checked with BLASTX (Altschul, 1997). The
functions of translated open-reading frames were searched by
BLASTP programs (Altschul et al., 1990) (E value ≤10−5)
and HHPRED (Soding et al., 2005) server, consulted between
November and December 2016. Protein parameters (isoelectric
point and molecular weight) were determined using Sequence
Manipulation Suite: Protein Isoelectric Point and Sequence
Manipulation Suite: Protein Molecular Weight (Stothard, 2000).
The presence of transmembrane domains was checked using
TMHMM (Käll and Sonnhammer, 2002) and Phobius (Käll
et al., 2004), and membrane proteins were annotated when
both tools were in concordance. The search of tRNA encoding
genes was performed using tRNAscan-SE (Schattner et al.,
2005). Putative promoters were searched using PromoterHunter
(Klucar et al., 2010), and putative regions were manually
verified. ARNold (Naville et al., 2011) was used to predict
rho-independent terminators and the energy was calculated
using Mfold (Zuker, 2003). Whole-genome comparisons between
EC3a and some of its closest relatives were performed using
progressiveMAUVE (Darling et al., 2010) and OrthoVenn
(Wang et al., 2015). Phage EC3a (KY398841) was compared
with E. coli phages vB_EcoS_ACG-M12 (JN986845), RTP
(AM156909), JK06 (DQ121662), phiJLA23 (KC333879), and T1
(AY216660).
Assessment of Phage Viability in Honey
Phage EC3a viability was tested in PF2 and U3 honeys. Briefly,
phage [2× 109 plaque forming unit (PFU).mL−1] was incubated
with both honeys at 25% (w/v) and 50% (w/v). Honeys will be
mentioned hereafter as PF2x%, and U3x%, where x corresponds to
the honey percentages in w/v of 25 and 50, respectively. Controls
were performed in sterile deionized water instead of honey. The
solutions were incubated at 37◦C and samples taken during 1 h
until 6 h to confirm that progeny phages have then time to
reach and infect a neighbor biofilm cell, and then after 12 and
24 h. Phage EC3a was quantified, at the different time-points,
according to the double agar overlay technique (Adams, 1959).
Briefly, 10-fold diluted phage suspension, 100 µL of host bacteria
culture, and 3 mL of TSA top agar were poured onto a Petri plate
containing a layer of TSA. After overnight incubation at 37◦C,
the PFUs were determined. Three independent experiments were
performed.
Biofilm Formation and Treatment
For biofilm formation, the turbidimetry of a 16 h E. coli inoculum
grown in TSB was adjusted to 0.13, and diluted 10-fold in TSB.
After, 200 µL were added to wells of a 96-well plate and plates
incubated for 24 h or 48 h, at 37◦C and 120 rpm (Orbital
Shaker ES-20/60; BIOSAN). In 48-h-old biofilms, at 24 h, 150 µL
medium were replaced with fresh TSB.
Three different biofilm treatments were evaluated: phage,
honey, and the combination of both agents. Phage treatments
were performed with a multiplicity of infection (MOI) of 10,
honey challenging was done with 25% (w/v) and 50% (w/v)
concentrations, and the combinatorial effect of phage–honey was
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accomplished using the concentrations used in the single-agent
experiments. Biofilms formed on 96-well plates as described
above, were washed twice with saline [0.9% (w/v) NaCl, VWR]
to remove all non-adhered cells. After, 200 µL of phage or honey
or combination of both was added to each well and the plates
incubated at 37◦C, 120 rpm (Orbital Shaker ES-20/60; BIOSAN).
The control biofilms of each treatment were performed in 100µL
2× TSB, and 100 µL SM buffer. Samples were taken at 0, 6,
12, and 24 h for viable cell quantification. Three independent
experiments were performed.
Viable Biofilm Cell Quantification
Viable cells in biofilms were quantified according to a previously
described procedure (Pires et al., 2011), with some modifications.
Briefly, honey and/or phage treated biofilm and also non-treated
controls were washed twice with saline, saline (200 µL) was
then added to each well, and with the aid of a pipette tip all
biomass detached from the bottom and walls. Serial dilutions
were performed in saline containing 1 mM ferrous ammonium
sulfate (Applichem Panreac) to assure that all non-infecting
phages were destroyed (Park et al., 2003). Samples (10 µL)
were plated on MacConkey Agar using the microdrop technique
(Naghili et al., 2013), plates incubated 16 h at 37◦C, and CFUs
determined.
Susceptibility of Surviving Biofilm Cells
to Phage
Distinct colonies (19–21 colonies) remaining after phage
and combined phage–honey treatments were tested for their
susceptibility to phage EC3a using the method of streaking a line
of cells through a perpendicularly streaked line of phage solution
(Moons et al., 2013).
Scanning Electron Microscopy Analysis
For scanning electron microscopy (SEM) visualization, biofilms
were formed on polystyrene coupons (NuncTM ThermanoxTM,
Thermo ScientificTM) placed on 24-well plates. Biofilm formation
and treatment was done as described above with volumes of
bacterial inoculum, honey and/or phage and solutions used in the
control assays adapted for a volume of 1 mL instead of 200 µL.
Biofilms were washed twice with saline and fixed with 2.5% (v/v)
glutaraldehyde (Thermo Fisher Scientific). Coupons were left at
4◦C for 1 h and sample dehydration was carried out in ethanol
series [30, 50, 70, 80, 90% (v/v), and absolute] (Fisher Chemical).
Biofilms were coated with gold and analyzed by NanoSEM [FEI
Nova 200 (FEG/SEM); EDAX—Pegasus X4M (EDS/EBSD)]. The
lengths and diameters of 6–10 untreated and treated E. coli cells
were measured.
Transmission Electron Microscopy
Analysis
Phage EC3a particles, before and after 6 h contact with honeys
PF2 and U3 at 25% (w/v) concentration, were sedimented by
centrifugation (25,000 × g, 60 min, 4◦C) and washed twice in
tap water by repeating the centrifugation step. Subsequently, the
suspension was deposited on copper grids with carbon-coated
Formvar films, stained with 2% (w/v) uranyl acetate (pH 4.0)
(Agar Scientific), and examined using a Jeol JEM 1400 (Tokyo,
Japan) transmission electron microscope (TEM).
Escherichia coli cells challenged with phage for 2 h, honey
and the combination of both for 12 h, were also visualized
by TEM along with the respective control samples. In brief,
samples were fixed with 2.5% (v/v) glutaraldehyde (Electron
Microscopy Sciences, Hatfield, United States) and 2% (v/v)
paraformaldehyde (Merck, Darmstadt, Germany) in phosphate
buffer 0.1 M with 0.5 mM MgCl2 (pH 6.5), dehydrated and
embedded in Epon resin (TAAB, Berks, England). Ultrathin
sections (40–60 nm thickness) were prepared on a RMC
Ultramicrotome (PowerTome, United States) using diamond
knives (DDK, Wilmington, DE, United States). The sections were
mounted on 200 mesh copper or nickel grids, stained with 2%
(w/v) uranyl acetate and 3% (w/v) lead citrate for 5 min each,
and examined under by TEM (Jeol JEM 1400, Tokyo, Japan).
Images were digitally recorded using a CCD digital camera
Orious 1100W, Tokyo, Japan.
Zeta Potential
Zeta potential of E. coli 24-h-old biofilm cells after 6, 12, and 24 h
treatment with phage, honey, and the combination of both was
determined by dynamic light scattering with a Malvern Zetasizer,
NANO ZS (Malvern Instruments Limited) and values were
calculated using the Smoluchowski equation (Hunter, 1981).
Briefly, biofilms were formed and treated as described above,
and after each treatment, wells were washed thrice with saline,
and surfaces scratched to detach biofilms. Samples (1 mL) were
collected into a 2 mL tube, homogenized and diluted 10-fold in
Milli-QTM water prior to each analysis. Each data value is an
average of three independent zeta potential measurements.
Flow Cytometry Analysis
Cell viability before and after single and mixed treatments was
assessed by flow cytometry as previously optimized (Cerca et al.,
2011) with some modifications. In brief, biofilms were washed
as described above, and resuspended in 200 µL. Then, 20 µL
of suspension was added to 180 µL of a solution containing
250 nM of SYTO R© BC Green Fluorescent Nucleic Acid Stain
(Thermo Fisher Scientific) and 20 µg.mL−1 of propidium iodide
(PI) (Thermo Fisher Scientific). The fluorescence of bacteria was
measured using an EC800 (SONY, San Jose, CA, United States)
flow cytometer. SYTO R© BC was detected on the FL1 channel and
PI on the FL4 channel. For all detected parameters, amplification
was carried out using logarithmic scales. Data were acquired and
analyzed using Sony EC800 Flow Cytometry Analyzer software.
Two independent experiments were performed in duplicate. Live
cells counts were determined subtracting the number of events
that were SYTO BC positive from the PI+ events.
Statistical Analysis
Statistical analysis of the results was performed using GraphPad
Prism 6. Mean and standard deviations (SD) were determined
for the independent experiments and the results were presented
as mean ± SD. Results were compared using two-way ANOVA,
with Turkey’s multiple comparison statistical test. Differences
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were considered statistically different if p≤ 0.05 (95% confidence
interval).
RESULTS
Honey Samples
Several honey samples collected from regional beekeepers were
characterized (Supplementary Table S1). Based on two main
characteristics—MGO content, a molecule reported as the major
antibacterial agent in honeys (Kilty et al., 2011), and MIC,
two honeys were selected for further characterization and
antimicrobial evaluation in E. coli biofilms. The honey with
lowest MIC [12.5% (w/v)] toward E. coli 434 was PF2 with an
MGO content of 316.6 mg.kg−1. The MIC of honeys tested
against another E. coli and toward S. aureus, P. aeruginosa,
and A. pittii revealed that 25% (w/v) was the predominant
MIC value of honeys but could decrease to as low as 3.125%
(w/v) as observed with S. aureus with honey E1. The honey
with highest MGO content was U3 with 2092.4 mg.kg−1 and a
MIC of 25% (w/v). PF2 is a polyflora honey having two main
floral sources [Castanea sativa (56%) and Eucalyptus spp. (26%)]
(Supplementary Table S2) and is a light amber honey with a
total protein content of 16.6 mg.g−1, HMF 47.9 mg.kg−1, pH
of 4.13, and a conductivity of 753 µS.cm−1. U3 honey is also
polyflora (30% Erica spp., 21% Rubus spp./Eriobotrya spp., and
18% C. sativa) and is dark amber, with a total protein content of
81.7 mg.g−1, HMF 204.6 mg.kg−1, pH 4.04, and a conductivity
of 622 µS.cm−1.
Morphology and Genome of Phage EC3a
EC3a forms clear plaques (Øplaque = 2.63 ± 0.35 mm)
surrounded by a halo (Øplaque+halo = 11.55 ± 1.61 mm)
(Figure 1a). EC3a has an icosahedral head with a diameter of
57 nm tapered with a non-contractile tail of 192 nm × 11 nm
with conspicuous striations, resembling members of the T1-like
phages of the Siphoviridae family (Figure 1b).
EC3a does not encode known genes associated with lysogeny
or toxin proteins, suggesting that it is potentially safe for therapy
applications. The genome consists of a linear double-stranded
DNA with 44,234 bp with a G+C% content of 44.2% (Figure 1c).
EC3a encodes 70 open reading frames (ORFs), tightly packed
occupying 91% of its genome. Twenty-five of the predicted
ORFs (36%) have an assigned function and four are unique
(Supplementary Table S3). Furthermore, one tRNA gene (tRNA-
Arg), 10 promotors, and 16 rho-independent terminators were
predicted. BLASTN search revealed homology of EC3a with
E. coli siphoviruses vB_EcoS_ACG-M12 (77% coverage; 93%
identity) and RTP (68% coverage; 89% identity). Furthermore,
OrthoVenn showed that approximately 83% of EC3a genes are
orthologous to vB_EcoS_ACG-M12 and RTP, 70% to phage
phiJLA23, 61% to JK06, and 54% to phage T1. This suggests
that EC3a is phylogenetically related with vB_EcoS_ACG-M12
and RTP and these three phages reunite the conditions for
the formation of a new genus. All EC3a ORFs were analyzed
with HHpred to identify a putative depolymerase which could
explain the halo formation (Figure 1a). ORF 35, a minor tail
protein (Supplementary Table S3) was found to present a cysteine
peptidase domain [NLPC_P60 (PF00877)] that is a putative tail-
associated endolysin domain.
Viability of Phage EC3a upon Contact
with Honey
Before antimicrobial experiments, the viability of phage was
inspected in PF2 and U3 honeys. EC3a was exposed to both
honeys at two concentrations—25% (w/v) and 50% (w/v)
(Figure 2a). In PF225%, there was only minor loss in viability
and EC3a concentration remained fairly stable along 24 h of
incubation. PF250% presented 3× 102 PFU.mL−1 at 6 h, however,
at 12 h no viable phages remained.
The viability of EC3a in U325% progressively decreased
with time until 12 h and by the end of 24 h incubation
2.6 × 103 PFU.mL−1 were still present in the samples. On the
other hand, U350% completely inactivated EC3a within 1 h upon
contact.
TEM imaging confirm that both honey presents antiviral
activity toward the phage (Figures 2b,c).
Antibiofilm Effect of Phage, Honey, and
Phage–Honey Combination on 24-h-Old
Biofilms
The effect of phage, honeys (PF2 and U3), and the phage–honey
combinations was evaluated in 24 h E. coli biofilms (Figure 3).
Single Agent Approach
Maximum antimicrobial activity in 24-h-old biofilms challenged
with EC3a phage occurred after 6 h treatment resulting in viable
cell reductions of 3.2 log. The increase of treatment to 12 h
showed less evident efficacy of EC3a (p < 0.05) and at 24 h no
apparent antibacterial of EC3a effect was perceived. PF225% and
PF250% resulted in the highest viable cell reductions at 12 h which
were approximately 3.6 and 5.9 log, respectively (Figures 3C,D).
The use of U3 honey, at both tested concentrations was not as
efficient as PF2 honey and phage EC3a (p < 0.05) in decreasing
biofilm cells at 6 h of treatment. Furthermore, at 6 h of treatment
U3 was less efficient than the phage itself. This tendency was,
however, inverted at 12 and 24 h. Overall, for a short (6 h)
treatment of E. coli biofilms the best selections using a single
agent approach were obtained using phage EC3a (3.2 log viable
cell reduction) or PF250 (5.1 log viable cell reduction). Biofilm
treatment during 12 h is more efficient using PF225% or PF250%
(3.6 and 5.9 log viable cell reductions, respectively) and 24 h
treatments were best with PF250% and U350% (5.5 and 3.1 log
viable cell reductions with PF2 and U3, respectively).
Phage–Honey Approach
The sum of viable cell reduction caused individually by phage and
PF225% was 4.8 logs at 12 h and 1.9 logs at 24 h. The combined
phage–PF225% strategy produced a synergistic effect that resulted
in a 5.9-log reduction at 12 h and 5.5-log reduction at 24 h,
respectively. Even though the reduction of viable cells at 6 h was
greater in the combined treatment, no additive or synergic effect
was detected. The viable cell reductions using PF250% and phage–
PF250% were equivalent (p > 0.05) and statistically higher than
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FIGURE 1 | Characteristics of EC3a. (a) Plaque morphology (black arrows indicate diameter of EC3a plaque and diameter of EC3a plaque and the surrounding halo.
Scale bar 1 cm), (b) virion particle, and (c) circular view of phage vB_EcoS_CEB-EC3a and TBLASTX comparison with the two closest E. coli phage homologs and
T1. The outer ring represents EC3a CDSs. The other three outer rings represent TBLASTX homologies with phages M12, RTP, and T1, respectively. The GC content
appears in the black ring, and the inner rings are the GC skew+ (green) and the GC skew− (pink). Some important EC3a genes are indicated.
the action of phage itself (p < 0.05). At 6 h, the antimicrobial
action of phage–U325% was significantly lower (p < 0.05) than
the effect achieved with phage, and similar (p > 0.05) to U325%
alone. However, after 12 h of treatment, phage–U325% displayed
an additive antimicrobial effect (p < 0.05) compared to the
treatment with each components individually (Figure 3C). No
significant differences were observed between U325% and phage–
U325% at 24 h post-treatment (p> 0.05) showing that honey alone
or combined with phage induced a similar response.
In general, these results point to a better biofilm control using
the phage–PF2 honey combination rather than the phage–U3
honey combination.
Antibiofilm Effect of Phage, Honey, and
Phage–Honey Combination on 48-h-Old
Biofilms
The effect of phage and the two honeys concentrations
individually and combined was also evaluated in 48 h E. coli
biofilms (Figure 4).
Single Agent Approach
Phage EC3a had minor and statistically similar (p > 0.05)
effect in 48-h-old biofilms treated during 6 and 12 h, and
no influence in reducing viable cells after 24 h. The effect
of PF2 honey, at both tested concentrations (Figures 4A,B),
was less efficient than the treatment effect obtained for 24-
h-old biofilms (Figure 3). PF225% had no effect after 6 h,
and only minor decrease of viable cell counts at 12 and
24 h (0.9 and 1.7 log, in average), respectively. Treatment
with PF250% (Figure 4B) exhibited slight antimicrobial effect
at 6 and 12 h (1.3 and 1.6 log reduction of viable cells),
increasing significantly (p < 0.05) to 3.4 log viable cell reduction
after 24 h. The effect of U3 honey in 48-h-old biofilms
resulted in similar (p > 0.05) viable cell reductions with
both concentrations (3.4 and 3.5 log with U325% and U350%,
respectively) (Figures 4C,D).
Phage–Honey Approach
Phage–PF225% effect was as follows: at 6 h the effect observed
was mostly due to phage infection since the viable cell counts of
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FIGURE 2 | Phage EC3a viability. (a) PFU counts after EC3a exposure to PF2 and U3 honeys at 25% (w/v) and 50% (w/v) concentrations, TEM micrographs of
EC3a phage tails after 6 h of contact with honeys with (b) U325% and (c) PF225%. Scale bar in TEM micrographs is 100 nm.
FIGURE 3 | Antibiofilm effect of phage EC3a, honey, and of the phage–honey combination on 24-h-old E. coli biofilms. (A) PF225%, (B) PF250%, (C) U325%,
(D) U350%. †Values present no reductions compared to control samples. ∗ Indicates that the difference is statistically significant at the p-value < 0.05 level.
the combinatorial treatment were identical to the phage results
alone; at 12 h the phage–honey combination acted synergistically
[sum of individual treatment (1.8 log) < result of combined
treatment (2.3 log)] and synergism maintained until the last time-
point of treatment [sum of individual treatment (1.7 log) < result
of combined treatment (3.0 log)]. Phage–PF250% reduced as
many viable cell counts at 6 h as each agent individually.
The increase of treatment to 12 h favored the combinatorial
approach (2.5 log viable cell reduction), that produced an additive
effect, in detriment of each individual approach (0.9 and 1.6 log
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FIGURE 4 | Antibiofilm effect of phage EC3a, honey, and of the phage–honey combination on 48-h-old E. coli biofilms. (A) PF225%, (B) PF250%, (C) U325%,
(D) U350%. †Values present no reductions compared to control samples. ∗ Indicates that the difference is statistically significant at the p-value < 0.05 level.
viable cell reductions with EC3a and PF250%, respectively). The
results recorded at 24 h revealed no differences between the
use of honey combined with phage or honey alone (p > 0.05).
A comparison of the effect of the phage–PF2 honey in 24- and
48-h-old biofilms reveals much higher efficacy of this honey
against younger (>5.5 log reduction of viable cells) than older
(∼3 log reduction of viable cells) biofilms. Phage–U325% resulted
also in an additive effect at 6 h, however, this combination
after 12 and 24 h of treatment resulted in cell reductions
similar to the ones registered for honey alone. Since there was
no action of the EC3a at 24 h, the result observed was only
due to the antimicrobial effect of honey. The same trend was
observed with phage combined with U350% after 12 and 24 h of
treatment.
Susceptibility of Surviving Cells to Phage
EC3a
The susceptibility of surviving colonies from 24-h-old biofilms
challenged with phage EC3a and the combined phage–honey
treatment to EC3a was tested. With the exception of 1 colony
obtained after combined treatment of phage–U350%, all other
surviving cells from phage–honey treatments were susceptible to
EC3a. On the other hand, 28.6% (6 out of 21 colonies assessed) of
colonies isolated after phage single treatment were insensitive to
EC3a (data not shown).
Insights of the Different Treatment Effects on E. coli
Scanning electron microscopy analysis
Cell morphology was assessed by SEM before and after honey,
phage, and combined honey–phage treatments to assess possible
changes. E. coli has a typical rod-shape form (length of
2.04 ± 0.26 µm and diameter of 0.54 ± 0.02 µm) (Figure 5a).
All treated cells retained their rod-shape morphology; however,
considerable phenomena associated to the exposure to honey
was detected. For instance, honey-mediated treatment caused:
(i) minor perturbations on the bacterial envelope unseen in
control E. coli (Figure 5b), (ii) shrinkage of cells with small
and pronounced collapsing of the bacterial envelope in the
septal and apical regions (Figures 5c–f), (iii) membrane ruﬄing
and/or possible membrane detachment (Figures 5d,e); (iv)
membrane disruption and leakage of the cytoplasmic content and
debris around the disintegrated cells (Figures 5f,j). Structural
alterations of the outer membrane such as disruption caused
cytoplasmic leakage from the apical and septal regions, and
these observations happened in the majority of cells imaged
after 12 and 24 h. Shrunk E. coli cells were shorter in length
(1.79 ± 0.20 µm) and had either wider (0.77 ± 0.09 µm) or
thinner (0.45 ± 0.07 µm) diameter in the mid-region area.
Besides shrinkage, honey disabled cell division (Figures 5g,h).
Cells exposed to phage showed formation of vesicle-like
structures, and in general higher amounts of cell debris on the
polystyrene surfaces (Figures 5i,j). The combined phage–honey
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FIGURE 5 | SEM micrographs showing the effect of honey, phage, and honey–phage combination treatments in E. coli cells. (a) Control E. coli, (b–i) honey
treatment, (j,k) phage treatment, (l–p) phage–honey treatment. The honey used in these experiments was PF2.
treatment exhibited a mixture of cell damage phenomena similar
to the observed in the individual treatments (Figures 5k–p). SEM
observations did not show simultaneous effect of both agents in
an individual cell. Changes of the E. coli morphology with honey
correlate with viability experiments (Figures 3, 4).
Transmission electron microscopy analysis
Untreated E. coli cells showed regular morphology, with
intact cell envelopes (Figure 6a). In the treated samples—
PF225%; U325%; phage EC3a; phage–PF225%; phage–U325%—it
was possible to observe morphological and integrity changes
in the surface layers and alterations in the cytoplasm density
(Figures 6b–f).
Honey and honey–phage effect were observed after 12 h
treatment, the time-point which provided synergistic effect.
Honey treatment apparently disclosed integral outer membranes,
however, with obvious damages in the inner cell. While U3
revealed a detachment of the outer membrane more notorious in
the apical sites, PF2, besides the same detachment phenomenon,
was able to induce cytoplasm-clearing sites in one zone of the cell
(Figures 6b,c). In both cases, the condensation of the cytoplasmic
material was noticed.
Phage EC3a effect on E. coli cells was analyzed by TEM after
2 h of treatment, taking into account the moment that phage
start to cause cell damage, but not total destruction that would
only result in images showing cell debris. Treatment with EC3a,
revealed evident irregularities in the cell wall shape. Besides, it
was possible to observe some outer membrane detachment, a less
dense cytoplasm and even cellular debris (Figure 6d).
The images obtained with the combination of phage and both
honeys revealed, besides the cell structure alterations reported
to each one separately, an increase on the amount of cell debris
(Figures 6e,f).
Zeta Potential
Measurements of zeta potential were carried out in 24-h-old
biofilm cells after 6, 12, and 24 h (Supplementary Figure S1). The
contribution of phage and honey to the background conductivity
of E. coli biofilm cells was found to be negligible with a variation
of no more than 0.3 mS.cm−1 (data not shown). At 6 h, control
and phage-treated samples had more negative and significantly
similar (p > 0.05) zeta potential values. Although all other
samples resulted in an increase in zeta potential of approximately
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FIGURE 6 | TEM micrographs showing the effect of honey, phage, and honey–phage combination treatments in E. coli cells. (a) Control E. coli, (b) PF225%,
(c) U325%, (d) EC3a phage at a MOI 10, (e) phage–PF225% at a MOI 10, (f) phage–U325% at a MOI 10 (arrows indicate membrane detachment and dashed arrows
point cell debris).
3.9–8.8 mV (to less negative values), a statistical difference
(p < 0.05) was only observed for phage–honey [50% (w/v)]
treated biofilms compared to control. The two concentrations
of honey tested [25% (w/v) and 50% (w/v)] imparted a similar
surface charge neutralizing effect. Samples analyzed after 12 h
of treatment yielded slight increase of zeta potential (less
negative values), however, only phage-treated biofilm cells were
statistically different (p < 0.05) compared to 6 h of treatment.
After 24 h of treatment, statistical differences (p < 0.05) in
comparison to the previous time-points were only obtained for
phage and combined phage–honey [50% (w/v)] treated samples.
Throughout the experiment, the sample pH values varied dimly
between 5 and 6, with slightly more acidic pH obtained for honey
concentrations of 50% (w/v) due to the low pH of honey itself.
All zeta potential measurements were performed immediately
following sample dilution (1:10) in Milli-QTM water and thus
potentially confounding influences arising from variations in pH
were minimized.
Treated and Untreated E. coli Biofilm
Analysis by Flow Cytometry
Flow cytometry using LIVE/DEAD staining was performed
to assess the effect of all treatments on the viability of 24-
h-old biofilm cells (Figure 7 and Supplementary Table S4).
E. coli control biofilms (Figure 7A) presented a great number
of viable cells as evidenced by the SYTO R© BC (SYTO) uptake
(SYTO+/PI−) and also a small fraction of compromised/injured
cells (SYTO+/PI+). After 12 h of treatment, PF225% and U350%
resulted in a substantially higher number of compromised
cells compared to the control (Figures 7B,D). On the other
hand, U325% had a similar amount of compromised cells than
the control biofilm (Figures 7A,C). Unexpectedly, all honeys,
regardless of the concentration used, caused an increase of
the SYTO mean fluorescent intensity from approximately 754
to 2.552, 2.525, and 1.666 for PF225%, U325%, and U350%,
respectively (Supplementary Table S4). Phage alone clearly
reduced the viable cell population, caused an increase of
damaged cells, and a higher amount of cell debris (Figure 7E)
compared to control biofilm (Figure 7A) resulting in a
decrease of approximately 1.5 log cells.mL−1. The amount of
cell debris (SYTO−/PI−) was greater using phage than both
honeys at 25% (w/v) (compare Figures 7B,C,E) but not at
all comparable to the amount of debris after treatment with
U350%.
The comparison of single agent treatments (Figures 7B–E)
with the combined treatments (Figures 7F–H) gives us an
indication of the population shifts as a result of the strategy
applied. The cytograms of the treatment with phage–PF225%
show a synergic effect (1.82 > 0.15 + 1.52) (Supplementary
Table S4). This observation is the result of the following findings:
(i) the core population was similar to the one obtained with honey
and the phage was able to infect the live cells that had the highest
uptakes of SYTO; (ii) an increase of cell debris compared to phage
and honey single treatments; (iii) less live cells compared to single
treatments.
The phage–U325% combination shaped massively the biofilm
driving into a diversified population in the live and compromised
quadrants (compare Figures 7C,E,G). It is perceptible that both
agents have a role in the progression of the biofilm treatment
evidenced by: (i) the population with the lowest SYTO uptake,
visible after phage single treatment, was present in the combined
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FIGURE 7 | Flow cytometric analysis after 12 h application of single and combined treatments to 24-h-old E. coli biofilms. Representative dot plot FL1 (x-axis) vs FL4
channel (y-axis) showing E. coli cells stained with SYTO BC (250 nM) and PI (20 µg.mL−1). (A) E. coli control, (B) PF225%, (C) U325%, (D) U350%, (E) EC3a phage at
a MOI 10, (F) phage–PF225% at a MOI 10, (G) phage–U325% at a MOI 10, (H) phage–U350% at a MOI 10. Results are a representative example of two independent
experiments.
strategy; (ii) the live population present in U325% was targeted by
EC3a reducing the total counts of this population.
The use of phage–U350% resulted in a lower amount of cell
debris than each single treatments, and similarly to U325%, phage
targeted preferentially cells with higher SYTO uptake (compare
Figures 7D,E,H).
DISCUSSION
Escherichia coli is frequent in the complex microenvironment
of chronic wound bed along with S. aureus and P. aeruginosa
(Moet et al., 2007; Petkovšek et al., 2009). Besides its relevance
in chronic wounds, E. coli is also the leading cause of urinary
tract infections, and one of the most common pathogens causing
blood stream infections, among other infections (Kerrn et al.,
2002; Kaper et al., 2004; Marrs et al., 2005; Rodriguez-Bano et al.,
2010; Martelius et al., 2015). Furthermore, the increasing rates
of antimicrobial resistance among E. coli are a growing concern
in both developed and developing countries (Von Baum and
Marre, 2005; Da Silva et al., 2012; Tadesse et al., 2012). Antibiotic
alternatives are therefore desired.
This study evaluated the individual and combined effect of two
antimicrobial agents—honey and phages. To our knowledge, this
is the first study assessing the impact of honey combined with
phages on the tested organism at both biofilm and cell structural
levels.
Honey was chosen based on the knowledge that at least
two complementary mechanisms are responsible to combat
infections: (i) the direct biocidal activity, due to the presence
of multiple factors that can damage susceptible organisms (high
sugar content, low pH, the generation of hydrogen peroxide,
bee defensin-1, various phenolic compounds and complex
carbohydrates, and the MGO) that combined enable prevention
and elimination of established biofilms and enhance wound
healing (Lu et al., 2014); and (ii) the anti-virulence activity,
through downregulation of expression of genes associated with
virulence factor production, stress tolerance, and/or multicellular
behaviors of the target organism (such as biofilm formation
and quorum sensing) (Wang et al., 2012), that is thought to
weaken bacterial coordination, decrease their survival abilities,
and interfere with their virulence mechanisms (Wasfi et al.,
2016). Portuguese honeys, 13 in total, were physicochemically
characterized and their MIC assessed. All honeys had MICs of
12.5% (w/v) or 25% (w/v) and thus one honey presenting each
MIC was selected. The honey selected for MICs of 12.5% (w/v)
and 25% (w/v) were PF2 and U3, respectively. Since MGO has
been identified as the dominant active antibacterial component
of Manuka honey (Mavric et al., 2008; Adams et al., 2009), this
criteria was used for the selection of the two honeys. However,
other physical properties, known for their antimicrobial role
could have also have been adopted, i.e., pH and HMF content,
among others. Although MGO plays an important role in
Manuka honey, a previous study using non-manuka honeys
against Clostridium perfringens suggests that other unknown
factors, rather than MGO, have a major role in the antimicrobial
effect observed (Oinaala et al., 2015).
Phages were selected due to their ability to target antibiotic-
resistant bacteria and bacterial biofilms, and due to the potential
depolymerases that they carry that allow their entry into
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the inner layers of the biofilms by degrading components of
the exopolymeric matrix (Bartell et al., 1966; Hughes et al.,
1998; Sillankorva et al., 2004; Pires et al., 2016). The phage
tested herein, phage EC3a, belongs to the Siphoviridae family,
possess a large halo (Figure 1), indicative of depolymerase
activity (Pires et al., 2016), and does not carry genes associated
with lysogeny or toxin proteins (Supplementary Table S3).
Comparative analysis of the genome of EC3a suggests that EC3a
along with its phylogenetically related vB_EcoS_ACG-M12 and
RTP phages could form a new genus. Typical putative lyase
domain was not found in EC3a, nevertheless, there is an active
peptidase domain in EC3a’s minor tail protein (ORF 35) that
might be responsible for the halo formation. Exopolysaccharide
depolymerase activity associated with tail fibers or with tail-spikes
has been described for Acinetobacter baumannii phage ϕAB6,
Erwinia amylovora phage L1, Pseudomonas putida phage ϕ15,
among others (reviewed in Pires et al., 2016).
Maximum reduction of viable cells caused by phage EC3a
was observed at 6 h; however, from this point forward the
antibiofilm efficacy declined until no effect was perceived at 24 h
of treatment (Figures 3, 4). This is in agreement with several
works which argument that short phage treatments are effective
nevertheless extended treatments cause regrowth of bacteria in
biofilms (Cornelissen et al., 2011; Pires et al., 2011; Chibeu et al.,
2012). Regrowth can be a consequence of dynamic adaptation or
bacterial tactics to avoid, circumvent or subvert phage infection
(Labrie et al., 2010). Regrowth of E. coli beyond 6 h of EC3a
phage treatment can be due to a fraction of the population
which became insensitive (28.6%) to the phage. These insensitive
mutants continue to thrive and secrete EPS that can mask phage
host receptors preventing adsorption of phages to the cells (Labrie
et al., 2010).
Both Portuguese honeys were tested at 25% (w/v) and 50%
(w/v) concentrations. These concentrations (2 × MIC and
4 × MIC for PF2 and 1 × MIC and 2 × MIC for U3), were
able to reduce E. coli viable cells from 24-h-old biofilms already
in 6 h, however, the higher honey concentrations were far more
effective. This study shows that the active substances in honey
were able to diffuse through the matrix of established E. coli
biofilms reaching and causing damage to the bacterial cells.
The effectiveness of PF2 honey was, however, highly influenced
by biofilm age, resulting in lower viable cell reductions after
treatment of mature biofilms (48-h-old). On the other hand,
U3’s effect was not at all influenced by the age of the biofilms
treated. A possible explanation for this fact might be related
to the high MGO content present in this honey since this
molecule holds strong antimicrobial and antibiofilm activity even
in mature biofilms (Paramasivan et al., 2014). Comparing the
results using 2 × MIC (PF25% and U350%), it is clear that PF2
is significantly more effective in reducing viable cell counts. It
has been previously reported that chestnut (C. sativa) honeys
presented high antibacterial activity against E. coli while Erica
honeys had no antimicrobial activity against two reference strains
E. coli (ATCC 25922) and Salmonella serovar Infantis (ATCC
1523), respectively (Coniglio et al., 2013). Although both honeys
tested in our work were polyfloral, PF2 presented a predominant
pollen of C. sativa (56%) while U3 had Erica spp. (30%) as
the most dominant secondary pollen (Supplementary Table S2).
Therefore, this higher antibacterial effectiveness of PF2 compared
to U3 is most probably due to the botanical source of the honeys.
Previous works with Manuka honey have reported biomass
reductions from established biofilms and impaired cell adhesion
of Streptococcus pyogenes, S. aureus, and P. aeruginosa when
17% up to 40% (w/v) concentrations were used to supplement
the media were biofilms were formed (Maddocks et al., 2012,
2013; Cooper et al., 2014). Furthermore, in these works, honey’s
effect in cell viability in developing and established biofilms was
evaluated by microscopy (LIVE/DEAD staining), where honey
was shown to increase the number of dead cells (Maddocks et al.,
2012, 2013; Cooper et al., 2014). Manuka did not eradicate these
pathogens, and therefore the biomass reductions were suggested
to be due to a combined effect of growth inhibition and cell
death. In our work, flow cytometry experiments did not show any
increase of cell death (SYTO−/PI+ quadrants in Figures 7B–D),
however, honey was greatly responsible for an increase of cells
with compromised membrane as visible in the SYTO+/PI+
quadrants. Furthermore, both tested honeys caused an increase of
the uptake of SYTO which has been described as a consequence
of the process of cells becoming permeabilized (Berney et al.,
2007). During the permeabilization event, intermediate states
in E. coli biofilm cells are occurring which result in different
intracellular concentrations of SYTO as a result of the degree of
destruction distressed on the bacterial membrane. Even though
the percentage of live cells after exposure to honey was still high,
these living cells were not able to grow once plated on agar
plates (Supplementary Table S4). In terms of flow cytometry cell
counts, the antibiofilm treatments caused reductions between
0.15 up to 1.82 log cells.mL−1 while the culturable cell counts
after treatment varied in the range of 1.21 to more than
5.85 CFU.mL−1. For instance, at 12 h of treatment, PF225% honey
resulted in culturable cell reductions higher than the limit of
detection, however, the live cell counts by flow cytometry showed
a 1.82 log reduction. Similar phenomena has been observed with
Canadian honeys tested on log phase E. coli which, by flow
cytometry, resulted in 26 to 7.8% of injured cells and above
40% of live cells which did not grow once plated (Brudzynski
and Sjaarda, 2014). This dissimilarity between culturable and
flow cytometry counts is possibly due to the presence of viable
but non-culturable cells (Cerca et al., 2011) which may be a
consequence of: (i) during the first stages of phage infection, cells
must remain viable to replicate new phage progeny and therefore
are detected in the SYTO+/PI− quadrant, however, once plated
these will not form colonies; (ii) when honey is applied, the minor
perturbations and shrinkage observed in cells might also affect
their cultivability.
Some authors describe honeys bacteriostatic effect on bacteria,
not allowing bacterial growth up to even 4 days (reviewed in
Molan, 1992). Our SEM analysis on E. coli biofilm cells (Figure 5)
show cell collapse and leakage of the cytoplasm. It is known
that bacterial survival requires integral membrane architecture
so that transmembrane potential can be regulated, as these
are essential requirements for growth as well as cell metabolic
activity. Thus, honeys action on E. coli biofilm cells makes them
completely unable to resume re-growth, thus contradicting the
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bacteriostatic assumption. Besides this work, to our knowledge,
cytoplasmic leakage due to honey has only been reported toward
S. aureus using honey from two stingless bees (Nishio et al.,
2016). The effect of MGO on E. coli and Bacillus subtilis has
been studied previously by other authors who observed that
with concentrations above 1 mM, both species presented fewer
fimbriae and flagella (Rabie et al., 2016). Additionally, MGO
alone has been shown to cause membrane damage and shrinkage
similar to the observations we report herein using PF2 honey.
Studies with MGO have also addressed Proteus mirabilis showing
that this compound was able to diffuse through an established
biofilm matrix and effectively kill bacterial cells (Majtan et al.,
2014). This suggests that in our samples the MGO content can be
responsible for shrinkage and membrane damage. Spheroplasts
formation in E. coli was induced by a buckwheat honey and these
spheroplasts were highly prone to lysis (Brudzynski and Sjaarda,
2014). The perturbations that honey caused in E. coli surface
included several phenomena that have been also described using
antibiotics and also antimicrobial peptides (Alves et al., 2010;
Prince et al., 2016). For instance, the antimicrobial peptides
BP100, a short cecropin A-melittin hybrid peptide, and pepR,
an antimicrobial peptide derived from the dengue virus, caused
all membrane deformations as those we observed with honey
(Alves et al., 2010). Nisin on the other hand, a polycyclic
antibacterial peptide and class I pore-forming bacteriocin,
forms pores that cause rapid dissipation of transmembrane
electrostatic potential resulting in membrane permeabilization
and rapid bacterial cell death. Electron microscopy of nisin-
treated E. coli showed, similarly to our results, minor changes
in the cell size (Prince et al., 2016), however, no cell collapse or
cytoplasmic leakage. The minor perturbations of the bacterial
envelope, shrinkage and collapse were more common in cells
imaged shortly after the beginning of the honey treatment
which points to an interaction of honey with the negatively
charged lipopolysaccharide (LPS) outer layer of E. coli cells
(Figure 5).
Several of these described effects on cell structure that
alter cell viability were corroborated and reinforced by TEM
images. In fact, the cell envelope shrinkage observed by TEM
in all samples treated with phage (Figures 6d–f) seemed
to be a similar phenomenon to the described by SEM,
that leaded subsequently to the disruption of the cell wall
and to the release of cellular content (Figures 5j–o). The
activity of both antimicrobials together is evidenced in these
images. Besides, the perturbations in the cell surface caused by
honey as visualized by SEM, detachment of the cytoplasmic
membranes and cytoplasm condensation were revealed by
TEM. The occurrence of clear zones in the central or apical
zones of cells may be inducing their collapse (Figures 5b–
i). The antimicrobial observations are not unique for honey.
For instance, the antimicrobial peptide arenicin shows similar
effects in cells—it causes membrane blebs formation, release
and condensation of cytoplasmic material, and detachment of
the outer membrane from the plasma membrane (Andrä et al.,
2008).
The combinatorial effect of phage and honey revealed
that phage–PF225% displayed higher antibiofilm activity than
honey alone throughout all the experiment, indicating that the
phage action was determinant in enhancing honey’s action.
Not surprisingly, EC3a phage remained active and highly
concentrated for 24 h in PF225%. However, more than an additive
effect, PF225% together with phage EC3a had a synergic influence
at both 12 and 24 h. This is a totally new outcome corroborated
by flow cytometry experiments showing that the simultaneous
application stemmed the progress of the E. coli biofilms with
phages targeting the cells with highest SYTO uptakes that PF2
honey failed to address. According to the SEM observations,
the use of phage–PF2 honey combination caused some biofilm
cells to be subject of phage attack and others to be damaged
and killed by honey. Until 4 h of phage exposure to U325%
the loss in viability was small suggesting that progeny EC3a
phages have enough time to reach and infect neighbor cells.
Nonetheless, no synergic effect of phage with this honey was
noticed. Therefore, synergy using phage and honey can be
honey and phage dependent. Coupling phages to high honey
concentrations [50% (w/v)] had no advantages since honey
alone destroyed already the vast majority of biofilm cells. This
can be a consequence of the higher antiviral activity of this
honey concentration. Nevertheless, an advantage of the treatment
combining phages with honey is the lower emergence of phage
insensitive mutants.
Cell surface charge is highly dependent on both the
composition of the surface and the nature of the surrounding
medium (Soon et al., 2011). Herein, we used zeta potential
to analyze cell surface charge. E. coli biofilm cells had always
negative zeta potential values (Supplementary Figure S1) without
any background conductivity alteration due to honey and/or
phages. The conductivity and pH are known to interfere in
the adsorption of ions onto bacterial cells and in the degree of
ionization of charged moieties on the cell surface (Hong and
Brown, 2008), however, this is not applicable to our study since
these conditions did not vary considerably. The dense negatively
charged barrier in Gram-negative bacteria is mostly a result
of several forces which are needed to stabilize divalent cations
that bind LPS molecules within the membrane (Peterson et al.,
1985). Besides LPS, the primary component of the outer leaflet,
the negative zeta potential of Gram-negative bacteria is also
dictated by the presence of a high number of fimbriae in the
cell morphology, capsule (Bayer and Sloyer, 1990; Soon et al.,
2011), and even the growth state of bacteria (Soon et al., 2011).
Our results show that honey treatment of biofilms led to cells
with less negative zeta potential values. The corresponding rise
in zeta potential of honey-treated biofilms is most plausibly
explained by the alterations that occurred in the cell morphology
that were visible by SEM in the E. coli outer membrane. This
is in agreement with some results where different antibiotics
led to less negatively charged zeta potential in Gram-negative
bacteria as a consequence of modification or complete loss of
LPS and/or lipid A from the outer membrane (Winfield et al.,
2005; Gooderham and Hancock, 2009; Moffatt et al., 2010).
Zeta potential values after 24 h treatment with phage and
phage–honey [50% (w/v)] were more negative. The difference
in the phage-alone 24 h treatment can be credited to the poor
effectiveness of the treatment at this time point that led to a high
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number of cells, insensitive to phage, surviving and continuing
their growth. These cells are most likely at the exponential phase
and this corroborates a few studies (Eboigbodin et al., 2006;
Bolster et al., 2010), where exponentially growing cells had more
negative zeta potential than stationary phase cells. However, the
phenomenon leading to a more negative zeta potential value
after phage–honey [50% (w/v)] are unknown and warrant further
investigation.
Summarizing, our results indicate that the activity of honey
at 25% (w/v) is enhanced by the addition of phages and the
resulting antimicrobial effect is similar to 50% (w/v) honey
applied to 24- and 48-h-old biofilms. This result reinforces the
potential use of both antimicrobials together, taking advantage
of honey’s antibiofilm activity, and of the phages ability to lyse
specific bacteria. Additionally, microbial resistance to honey has
never been reported, and their antiviral effect is advantageous
compared to phage therapy alone, reducing the emergence of
phage insensitive mutants. The use of a more diluted honey
solution is known to be advantageous, not only due to a
potential lower cost of treatment, but also since a more liquid
solution might be therapeutically more desirable as a topical
rinsing solution maximizing the tolerability and practicality of
the delivery technique. The pioneering combined delivery of
phage and honey is thus a promising antimicrobial alternative,
particularly in the treatment of chronic wound infections with
E. coli and can be an option also for other species that do not
respond to antibiotic therapy.
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